Laura Vaingard

Laura Vaingard

Public Policy Expert
Laura Vaingard offers insights on healthcare reform for public policy professionals,  suggesting various interventions government officials can implement nationally to alleviate poor healthcare practices. She advocates for healthcare reform for rural communities and expanded access to mental health services, while also discussing the economics of prescription drug pricing.
How Will West Virginia Reform Prior Authorization Laws?
Public Policy How Will West Virginia Reform Prior Authorization Laws?

Approximately 87% of oncology practitioners believe that the current systems for appealing insurance denials are neither reasonable nor adequate for patient needs. This startling statistic underscores the motivation behind West Virginia’s recent enactment of House Bill 4965, a transformative piece o

Delaware Enhances Oversight of Hospital Charity Care Rules
Public Policy Delaware Enhances Oversight of Hospital Charity Care Rules

Senate Bill 13 codifies a tiered discount system designed to protect middle-income families from the predatory nature of mounting medical debt. This legislation represents a pivot point for Delaware’s healthcare landscape, as the state moves aggressively to regulate the financial practices of n

Is Medicare Physician Payment Reform Just an Illusion?
Public Policy Is Medicare Physician Payment Reform Just an Illusion?

Regulatory innovation allows the Centers for Medicare & Medicaid Services to modernize payment models, but the agency lacks the authority to fix fundamental instabilities in the law. This inherent tension between administrative flexibility and statutory rigidity defines the current landscape of

FDA Cites Safety Failures at Houston RX Compounding Pharmacy
Care FDA Cites Safety Failures at Houston RX Compounding Pharmacy

While the demand for affordable semaglutide and tirzepatide surges, the FDA’s findings at a Texas facility highlight the hidden risks of unregulated manufacturing. The pharmaceutical landscape in 2026 continues to be shaped by the immense popularity of GLP-1 receptor agonists, which has created a m

What Is the FDA’s New Guidance for Surgical Robotics?
Public Policy What Is the FDA’s New Guidance for Surgical Robotics?

The FDA's focus on teleoperated systems acknowledges the unique risks inherent in having a software interface sit between the surgeon's hand and the patient's tissue. This realization marks a transformative moment in medical device oversight, as the agency moves to solidify the

FDA Clears Implicity’s AI to Reduce Cardiac Alert Fatigue
Process FDA Clears Implicity’s AI to Reduce Cardiac Alert Fatigue

The ILR ECG Analyzer operates in the cloud to re-evaluate signals that have already been flagged by a device’s internal manufacturer-specific filtering system. This landmark achievement follows the U.S. Food and Drug Administration granting 510(k) clearance to the next-generation software, marking a

How Does the FDA Expansion of Anktiva Impact Bladder Cancer?
Care How Does the FDA Expansion of Anktiva Impact Bladder Cancer?

By activating both natural killer cells and T-cells, Anktiva creates a targeted immune environment that helps preserve the bladder while effectively managing aggressive urothelial carcinoma. This specialized immunotherapy represents a critical evolution in the treatment of non–muscle-invasive b

FDA Flags Safety Governance Failures in Newron Clinical Trial
Care FDA Flags Safety Governance Failures in Newron Clinical Trial

Establishing a 24-hour reporting requirement for site-to-sponsor communication is becoming a necessary standard for managing high-risk Central Nervous System research programs. The recent identification of a lethal safety signal regarding an investigational compound, evenamide, has sent significant

Oklahoma Lawmakers Study Safety Risks of Kratom and THC Drinks
Public Policy Oklahoma Lawmakers Study Safety Risks of Kratom and THC Drinks

Forensic toxicologists have officially identified mitragynine as one of the top five substances involved in overdose deaths in Oklahoma, alongside fentanyl and methamphetamine. This stark finding served as the catalyst for a comprehensive interim study initiated by the Oklahoma House Alcohol,

How Can Republicans Win the Healthcare Debate?
Public Policy How Can Republicans Win the Healthcare Debate?

The current healthcare system often forces families into comprehensive plans that include expensive coverage features they may never actually require or use. This environment has created a significant opening for political messaging that prioritizes individual autonomy over rigid governmental

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later